Low recovery rates of high-level aminoglycoside-resistant enterococci could be attributable to restricted usage of aminoglycosides in Indian settings

J Med Microbiol. 2008 Mar;57(Pt 3):397-398. doi: 10.1099/jmm.0.47604-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminoglycosides / pharmacology*
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial*
  • Enterococcus faecalis / drug effects*
  • Enterococcus faecalis / isolation & purification
  • Enterococcus faecium / drug effects*
  • Enterococcus faecium / isolation & purification
  • Feces / microbiology
  • Gentamicins / pharmacology
  • Gentamicins / therapeutic use
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / epidemiology*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • India / epidemiology
  • Microbial Sensitivity Tests / standards
  • Prevalence
  • Streptomycin / pharmacology
  • Streptomycin / therapeutic use

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Gentamicins
  • Streptomycin